Longitudinal follow up of dysglycemia in overweight and obese pediatric patients

Pediatric Diabetes

Volumn 19, Issue 2, 2018, Pages 199-204

  Love Osborne, Kathy A ^a   Sheeder, Jeanelle L ^a   Nadeau, Kristen J ^a   Zeitler, Phil ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

community health; dysglycemia; obesity; prediabetes; youth

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BLACK PERSON; BODY MASS; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; DISEASE EXACERBATION; DYSGLYCEMIA; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JUVENILE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCHOOL CHILD; BLOOD; BODY WEIGHT GAIN; BODY WEIGHT LOSS; CLINICAL TRIAL; COLORADO; COMPLICATION; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; RETROSPECTIVE STUDY; RISK; WEIGHT LOSS PROGRAM;

ADOLESCENT; BODY MASS INDEX; CHILD; COLORADO; DELIVERY OF HEALTH CARE, INTEGRATED; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; OVERWEIGHT; PEDIATRIC OBESITY; PREDIABETIC STATE; PREVALENCE; RETROSPECTIVE STUDIES; RISK; WEIGHT GAIN; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 85041946571     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12570     Document Type: Article

References (21)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
2. Love-Osborne KA, Sheeder J, Svircev A, Chan C, Zeitler P, Nadeau KJ. Use of glycosylated hemoglobin increases diabetes screening for at-risk adolescents in primary care settings. Pediatr Diabetes. 2013;14(7):512-518.
3. Ramachandran A, Snehalatha C, Samith SA, Nanditha A. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance—analysis of the Indian Diabetes Prevention Programmes. Diabet Med. 2012;29(1):94-98.
4. Mukai N, Doi Y, Ninomiya T, et al. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study. Diabet Med. 2012;29(1):99-106.
5. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care. 2000;23(12):1770-1773.
6. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800-811.
7. Zhang X, Gregg EW, Williamson DF, et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care. 2010;33(7):1665-1673.
8. Vijayakumar P, Nelson RG, Hanson RL, Knowler WC, Sinha M. HbA1c and the prediction of type 2 diabetes in children and adults. Diabetes Care. 2017;40(1):16-21.
9. Liese AD, D'Agostino RB Jr, Hamman RF, et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118(4):1510-1518.
10. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Gruters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity—a problem that is no longer restricted to minority groups. Eur J Endocrinol. 2004;151(2):199-206.
11. Kleber M, Lass N, Papcke S, Wabitsch M, Reinehr T. One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet Med. 2010;27(5):516-521.
12. Dolan LM, Bean J, D'Alessio D, et al. Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents. J Pediatr. 2005;146(6):751-758.
13. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28(4):902-909.
14. Giannini C, Weiss R, Cali A, et al. Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes. 2012;61(3):606-614.
15. Nowicka P, Santoro N, Liu H, et al. Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011;34(6):1306-1311.
16. Franks PW, Hanson RL, Knowler WC, et al. Childhood predictors of young-onset type 2 diabetes. Diabetes. 2007;56(12):2964-2972.
17. Zeitler P, Hirst K, Pyle L, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247-2256.
18. Chan CL, Pyle L, Kelsey M, Newnes L, Zeitler PS, Nadeau KJ. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia-1,5-anhydroglucitol, fructosamine, and glycated albumin. Pediatr Diabetes. 2016;17(3):206-211.
19. Chan CL, Pyle L, Kelsey MM, et al. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes. Pediatr Diabetes. 2016;22.
20. Kim JY, Goran MI, Toledo-Corral CM, Weigensberg MJ, Shaibi GQ. Comparing glycemic indicators of prediabetes: a prospective study of obese Latino Youth. Pediatr Diabetes. 2015;16(8):640-643.
21. Gulati AK, Kaplan DW, Daniels SR. Clinical tracking of severely obese children: a new growth chart. Pediatrics. 2012;130(6):1136-1140.